Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Redhill Biophrma ADR (NQ: RDHL ) 9.020 -0.510 (-5.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Redhill Biophrma ADR < Previous 1 2 3 4 5 6 7 8 9 Next > RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants April 11, 2022 Via Benzinga 64 Biggest Movers From Yesterday March 18, 2022 Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... Via Benzinga Redhill Biopharma: Q4 Earnings Insights March 17, 2022 Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea March 15, 2022 Via Benzinga Earnings Scheduled For March 17, 2022 March 17, 2022 Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... Via Benzinga Redhill Biopharma's Earnings: A Preview March 16, 2022 Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 15, 2022 During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... Via Benzinga RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients March 01, 2022 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced topline results from the Phase 2 part of the Phase 2/3 study of RHB-107 (upamostat) in non-hospitalized... Via Benzinga RedHill Biopharma's COVID-19 Antiviral Cuts Mortality By 70% In Remdesivir Treated Patients February 07, 2022 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced results from two recently completed prespecified analyses from the oral opaganib Phase 2/3 study in hospitalized severe COVID-19. Via Benzinga 18 Stocks Moving in Friday's Pre-Market Session January 14, 2022 Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc... Via Benzinga RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance January 13, 2022 RedHill Biopharma Ltd (NASDAQ: RDHL) announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study patients in COVID-19 patients. The... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 30, 2021 Gainers Kiora Pharmaceuticals (NASDAQ:KPRX Via Benzinga 63 Biggest Movers From Yesterday December 31, 2021 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its... Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session December 30, 2021 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future... Via Benzinga Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday December 14, 2021 Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga RedHill Biopharma's Talicia Recommended For H. Pylori Infection December 09, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed prescribing of... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 09, 2021 Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! Via InvestorPlace Exposures Product Safety RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations December 06, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) announced that opaganib's proposed mechanism of action is not impacted by spike protein mutations. Opaganib is expected to be... Via Benzinga Exposures COVID-19 RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI December 02, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection. The new publication, describing a ... Via Benzinga The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout November 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... Via Benzinga Exposures Product Safety Earnings Scheduled For November 30, 2021 November 30, 2021 Companies Reporting Before The Bell • Hello Gr (NASDAQ:MOMO) is estimated to report quarterly earnings at $0.31 per share on revenue of $573.63 million. • UP... Via Benzinga Earnings Preview For Redhill Biopharma November 29, 2021 Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Tuesday, 2021-11-30. Here's what investors need to know before the announcement. Analysts... Via Benzinga 52 Biggest Movers From Friday November 22, 2021 Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session November 19, 2021 Gainers CASI Pharmaceuticals (NASDAQ:CASI Via Benzinga Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble November 19, 2021 Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's Intraday Session November 19, 2021 Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... Via Benzinga Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge November 19, 2021 Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 33 Stocks Moving In Friday's Mid-Day Session November 19, 2021 Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies highlighted the launch of second electric industrial... Via Benzinga Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views November 19, 2021 Following the market opening Friday, the Dow traded down 0.66% to 35,634.40 while the NASDAQ rose 0.54% to 16,079.51. The S&P also fell, dropping 0.03% to 4,703.27. The U.S.... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial November 19, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.